APA (7th ed.) Citation

Hughes, T. P., Deininger, M., Hochhaus, A., Branford, S., Radich, J., Kaeda, J., . . . Goldman, J. M. (2006). Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: Review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood, 108(1), . https://doi.org/10.1182/blood-2006-01-0092

Chicago Style (17th ed.) Citation

Hughes, Timothy P., et al. "Monitoring CML Patients Responding to Treatment with Tyrosine Kinase Inhibitors: Review and Recommendations for Harmonizing Current Methodology for Detecting BCR-ABL Transcripts and Kinase Domain Mutations and for Expressing Results." Blood 108, no. 1 (2006). https://doi.org/10.1182/blood-2006-01-0092.

MLA (9th ed.) Citation

Hughes, Timothy P., et al. "Monitoring CML Patients Responding to Treatment with Tyrosine Kinase Inhibitors: Review and Recommendations for Harmonizing Current Methodology for Detecting BCR-ABL Transcripts and Kinase Domain Mutations and for Expressing Results." Blood, vol. 108, no. 1, 2006, https://doi.org/10.1182/blood-2006-01-0092.